Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for primary supratentorial intracerebral hemorrhage
ChiCTR-TRC-10001141Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone in intracerebral hemorrhage (ICH) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Perihematomal edema, Mortality and 3 more. Started Mar 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR-TRC-10001141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001141.